Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

Open access

Abstract

Warfarin dosing is correlated with polymorphisms in vitamin K epoxide reductase complex 1 (VKORC1) and the cytochrome P450 2C9 (CYP2C9) genes. Recently, the FDA revised warfarin labeling to raise physician awareness about these genetic effects. Randomized clinical trials are underway to test genetically based dosing algorithms. It is thus important to determine whether common single nucleotide polymorphisms (SNPs) in other gene(s) have a large effect on warfarin dosing. A retrospective genome-wide association study was designed to identify polymorphisms that could explain a large fraction of the dose variance. White patients from an index warfarin population (n = 181) and 2 independent replication patient populations (n = 374) were studied. From the approximately 550 000 polymorphisms tested, the most significant independent effect was associated with VKORC1 polymorphisms (P = 6.2 × 10−13) in the index patients. CYP2C9 (rs1057910 CYP2C9*3) and rs4917639) was associated with dose at moderate significance levels (P ∼ 10−4). Replication polymorphisms (355 SNPs) from the index study did not show any significant effects in the replication patient sets. We conclude that common SNPs with large effects on warfarin dose are unlikely to be discovered outside of the CYP2C9 and VKORC1 genes. Randomized clinical trials that account for these 2 genes should therefore produce results that are definitive and broadly applicable.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2008-01-134247

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 33 references

Cited by

See all 517

Metadata

Authors
Cooper, G. M., Johnson, J. A., Langaee, T. Y., Feng, H., Stanaway, I. B., Schwarz, U. I., Ritchie, M. D., Stein, C. M., Roden, D. M., Smith, J. D., Veenstra, D. L., Rettie, A. E., & Rieder, M. J.
Affiliations
  • University of Washington (US)
  • University of Florida Health (US)
  • Department of Pharmacy Practice and Center for Pharmacogenomics and
  • Western University (CA)
  • Departments of Molecular Physiology and Biophysics and
  • Vanderbilt University (US)
  • Departments of Pharmacy and
Venue
Blood
Published
2008-08-15
Volume
112
Issue
4
Pages
1022-1027
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2037171637
Cited by
481
References
33
Citations by year
2026: 1 · 2025: 3 · 2024: 12 · 2023: 19 · 2022: 15 · 2021: 17 · 2020: 33 · 2019: 16 · 2018: 15 · 2017: 24 · 2016: 14 · 2015: 22 · 2014: 30 · 2013: 48 · 2012: 63
FWCI
45.24
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of Florida
  • University of Washington
  • National Heart, Lung, and Blood Institute (U01 HL-65962, U01HL065962)
  • National Institute of General Medical Sciences (GM 68797, U01GM074492, R01GM068797)
  • National Institute of Neurological Disorders and Stroke (NS053646, R01NS053646)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Nutrition, Genetics, and Disease
Keywords
warfarin, maintenance dose, genetic polymorphism, single nucleotide polymorphisms, VKORC1, CYP2C9, pharmacogenetics, genome-wide association study, anticoagulation
MeSH terms
Aryl Hydrocarbon Hydroxylases, Genotype, Humans, Mixed Function Oxygenases, Pharmacogenetics, Retrospective Studies, Warfarin, Randomized Controlled Trials as Topic, Polymorphism, Single Nucleotide, Genomics, Vitamin K Epoxide Reductases, Cytochrome P-450 CYP2C9

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose. https://app.cochat.ai/papers/10.1182/blood-2008-01-134247
The paper
Cooper, G. M., Johnson, J. A., Langaee, T. Y., Feng, H., Stanaway, I. B., Schwarz, U. I., Ritchie, M. D., Stein, C. M., Roden, D. M., Smith, J. D., Veenstra, D. L., Rettie, A. E., & Rieder, M. J. (2008). A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose. Blood. https://doi.org/10.1182/blood-2008-01-134247

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.